<b>Conclusions</b>: Elevated levels of inflammatory cytokines (IL-6, IL-1β, IFN-γ) and NO were associated with higher CRC risk, suggesting their potential as early biomarkers. The gene discussed is IL1B; the disease is colorectal carcinoma.